UBS downgrades Teva to promote as CEO exit, ongoing litigation cloud the pharma inventory’s…
It is time to promote Teva inventory because it's going through a interval of serious draw back amid a section of uncertainty, in accordance with UBS. UBS on Friday downgraded shares of the pharmaceutical firm to promote from impartial…